An Open-label Study of KW-3357

NCT01384903 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

221

Enrollment

INDUSTRY

Sponsor class

Conditions

Disseminated Intravascular Coagulation (DIC)

Interventions

DRUG: KW-3357
DRUG: Plasma-derived antithrombin

Sponsor

Kyowa Kirin Co., Ltd.